Dr. Carroll D. Scroggin Jr., MD

Dr. Scroggin practices at NEA Baptist Memorial Hospital in Jonesboro, Arkansas, part of Baptist Memorial Health Care.

Dr. Scroggin's NPI, 1821058991, was assigned on March 24, 2006. Dr. Scroggin graduated from University of Arkansas For Medical Sciences College of Medicine in 1985. Dr. Scroggin holds Arkansas license C-6880.

Dr. Scroggin's primary practice is NEA Baptist Memorial Hospital, at 4800 East Johnson Avenue, Jonesboro, AR 72405 in Craighead County. The practice phone is (870) 972-7000.

Dr. Scroggin's primary practice is NEA Baptist Memorial Hospital in Jonesboro, Arkansas, part of Baptist Memorial Health Care. Dr. Scroggin is also affiliated with St. Bernards Medical Center. The medical group on file is NEA Baptist Memorial Hospital. Dmand AI also links Dr. Scroggin to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Scroggin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scroggin practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Scroggin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Scroggin is board certified in internal medicine by the American Board of Internal Medicine. Dr. Scroggin is licensed in Arkansas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and prostate cancer among the conditions Dr. Scroggin treats.

CMS data shows 861 Medicare services from Dr. Scroggin across 10 procedure codes in 2024, for 407 Medicare patients. Medicare paid $49,840 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 407 Medicare patients who saw Dr. Scroggin in 2024. The largest group is 75 to 84, with 167 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scroggin's median patient age at 74, with 65% women.

In 2024, Dr. Scroggin wrote 1,103 Medicare Part D claims for 192 patients. 82% of them were for generic drugs. CMS names the drug for 891 of them, across 22 drugs with 11 or more claims each, at $2,143,964 in total drug cost. In 2023, CMS named 685 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Scroggin for performance year 2024, reported as part of a group. Dr. Scroggin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Scroggin to 10 clinical trials, 5 of them phase 2 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 10.

CMS Open Payments shows 381 general payments to Dr. Scroggin from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Pfizer Inc. paid the most, $682.

Dr. Scroggin graduated from University of Arkansas For Medical Sciences College of Medicine in 1985.

Dr. Scroggin is in network with 11 carriers, including Aetna, Cigna and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.